-5 The first line of treatment of GDM is insulin, but its various disadvantages including parenteral application, i.e., need for multiple injections, risk of hypoglycemia, maternal weight gain, and higher cost decrease the compliance of the patients to the use of insulin.3 This evidence concerns the gene INS and gestational diabetes.